Literature DB >> 15296085

Antimycobacterial arylidenecyclohexanones and related Mannich bases.

J R Dimmock1, N M Kandepu, U Das, G A Zello, K H Nienaber.   

Abstract

Several series of 2-arylidenecyclohexanones and related Mannich bases as well as various 2,6-bis(arylidene)cyclohexanones were evaluated against Mycobacterium tuberculosis H37Rv. Using a concentration of 12.5 microg/ml, nearly half of the unsaturated ketones inhibited the growth of the microorganism by 21-66% while all of the Mannich bases achieved 99% or greater inhibition. The relative hydrophobicities and widths of the molecules may have been contributing factors as to whether bioactivity was present or absent. Two of the Mannich bases demonstrated noteworthy potencies towards Mycobacterium avium. The conclusion was drawn that Mannich bases of 2-arylidenecyclohexanones represent a novel class of antimycobacterials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296085     DOI: 10.1002/chin.200447216

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  2-[4-(4-Methoxyphenylcarbonyloxy)benzylidene]-6-dimethylaminomethyl cyclohexanone hydrochloride: a Mannich base which inhibits the growth of some drug-resistant strains of Mycobacterium tuberculosis.

Authors:  S Das; U Das; B Bandy; D K J Gorecki; J R Dimmock
Journal:  Pharmazie       Date:  2010-11       Impact factor: 1.267

2.  N-Aroyl-3,5-bis(benzylidene)-4-piperidones: a novel class of antimycobacterial agents.

Authors:  Umashankar Das; Swagatika Das; Brian Bandy; James P Stables; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2008-02-08       Impact factor: 3.641

Review 3.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

Review 4.  Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).

Authors:  Dinesh Shetty; Yong Joon Kim; Hyunsuk Shim; James P Snyder
Journal:  Molecules       Date:  2014-12-24       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.